No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.